Our findings not only demonstrated normalization of ALT in parallel with a significant decrease in hepassocin after treatment for hyperthyroidism, but they also revealed the regulations of hepassocin expression under thyrotoxicosis using a HepG2 cell model. The gene discussed is FGL1; the disease is thyrotoxicosis.